PHOX2B expression was not detected in normal tissue, in constrast with many solid tumour immunotherapy targets, including HER2, or chemotherapy (such as camptothecin) targets in neuroblastoma, including TOP1, each of which demonstrates significant expression in normal tissue (Fig. 1e). The gene discussed is PHOX2B; the disease is neuroblastoma.